After treatment with propionate, propionate disrupted HDAC3-FOXK1 interaction to increase acetylation of FOXK1, resulting in reduced protein stability of FOXK1, blocked interferon signaling and deactivation of RA-FLSs. Here, FOXK1 is linked to rheumatoid arthritis.